Monitoring in real-time. Detecting changes in hemodynamic features. Alerting response. Enabling early treatment.
First medical device with an
alert of an impending stroke
based on biological mimicry.
Avertto learns personalized hemodynamic features using unique long-term big data.
Avertto’s algorithm continuously detects asymmetry by identifying deviations from baseline.
Avertto identifies hemodynamic risks, notifying and calls responsive care; enabling early intervention.
100% sensitivity, 86% specificity- using passive bilateral carotid sensors.
Alerts within the therapeutic window — when imaging and thrombectomy were still an option
Neurological deterioration was associated with pronounced asymmetry
Severe MCA stroke led to death after 11 months; estimated costs $300K–$675K
.png)
Meron is a Product Manager with a practical technical background and hands-on R&D experience. He leads requirements, prioritization, and cross-functional delivery while aligning product goals with engineering constraints. He brings expertise in mechanical and electrical systems.
